Serologic markers of brain injury and cognitive function after cardiopulmonary bypass

Annals of Surgery

Volumn 244, Issue 4, 2006, Pages 593-600

  Ramlawi, Basel ^a   Rudolph, James L ^b,c   Mieno, Shigetoshi ^a   Khabbaz, Kamal ^a   Sodha, Neel R ^a   Boodhwani, Munir ^a   Levkoff, Sue E ^b   Marcantonio, Edward R ^a   Sellke, Frank W ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3A; INTERLEUKIN 6; NEURON SPECIFIC ENOLASE; PEROXIDE; PROTEIN S100B; TAU PROTEIN;

ADULT; AGED; ARTICLE; BRAIN INJURY; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; COGNITIVE DEFECT; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART VALVE SURGERY; HUMAN; INCIDENCE; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

AGED; BIOLOGICAL MARKERS; BRAIN DISEASES; CARDIOPULMONARY BYPASS; COGNITION DISORDERS; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES;

EID: 33748926129     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000239087.00826.b4     Document Type: Article

References (41)

1. Ahonen J, Salmenpera M. Brain injury after adult cardiac surgery. Acta Anaesthesiol Scand. 2004;48:4-19.
2. Arrowsmith JE, Grocott HP, Reves JG, et al. Central nervous system complications of cardiac surgery. Br J Anaesth. 2000;84:378-393.
3. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA guidelines for coronary artery bypass graft surgery: executive summary and recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1991 guidelines for coronary artery bypass graft surgery). Circulation. 1999;100:1464-1480.
4. Murkin JM. Etiology and incidence of brain dysfunction after cardiac surgery. J Cardiothorac Vasc Anesth. 1999;3(4 suppl 1):12-17; discussion 36-37.
5. Jonsson H, Johnsson P, Backstrom M, et al. Controversial significance of early S-100B levels after cardiac surgery. BMC Neurol. 2004;4:24.
6. Kalman J, Juhasz A, Bogats G, et al. Elevated levels of inflammatory biomarkers in the cerebrospinal fluid after coronary artery bypass surgery are predictors of cognitive decline. Neurochem Int. 2006;48:177-180.
7. Lloyd CT, Ascione R, Underwood MJ, et al. Serum S-100 protein release and neuropsychologic outcome during coronary revascularization on the beating heart: a prospective randomized study. J Thorac Cardiovasc Surg. 2000;119:148-154.
8. Rasmussen LS, Christiansen M, Hansen PB, et al. Do blood levels of neuron-specific enolase and S-100 protein reflect cognitive dysfunction after coronary artery bypass? Acta Anaesthesiol Scand. 1999;43:495-500.
9. Reiber H. Dynamics of brain-derived proteins in cerebrospinal fluid. Clin Chim Acta. 2001;310:173-186.
10. Shaw GJ, Jauch EC, Zemlan FP. Serum cleaved tau protein levels and clinical outcome in adult patients with closed head injury. Ann Emerg Med. 2002;39:254-257.
11. Vaage J, Anderson R. Biochemical markers of neurologic injury in cardiac surgery: the rise and fall of S-100beta. J Thorac Cardiovasc Surg. 2001;122:853-855.
12. Westaby S, Saatvedt K, White S, et al. Is there a relationship between serum S-100beta protein and neuropsychologic dysfunction after cardiopulmonary bypass? J Thorac Cardiovasc Surg. 2000;119:132-137.
13. Hall RI. Serum S-100beta protein and postoperative neurological dysfunction: ready for prime time? Can J Anaesth. 2004;51:645-648.
14. Jonsson H, Johnsson P, Alling C, et al. S-100beta after coronary artery surgery: release pattern, source of contamination, and relation to neuropsychological outcome. Ann Thorac Surg. 1999;68:2202-2208.
15. Ueno T, Iguro Y, Yamamoto H, et al. Serial measurement of serum S-100B protein as a marker of cerebral damage after cardiac surgery. Ann Thorac Surg. 2003;75:1892-1897; discussion 1897-1898.
16. Wang KJ, Wu HH, Fang SY, et al. Serum S-100 beta protein during coronary artery bypass graft surgery with or without cardiopulmonary bypass. Ann Thorac Surg. 2005;80:1371-1374.
17. Nygaard O, Langbakk B, Romner B. Neuron-specific enolase concentrations in serum and cerebrospinal fluid in patients with no previous history of neurological disorder. Scand J Clin Lab Invest. 1998;58:183-186.
18. Murkin JM, Newman SP, Stump DA, et al. Statement of consensus on assessment of neurobehavioral outcomes after cardiac surgery. Ann Thorac Surg. 1995;59:1289-1295.
19. Gao L, Taha R, Gauvin D, et al. Postoperative cognitive dysfunction after cardiac surgery. Chest. 2005;128:3664-3670.
20. Royter V, Bornstein N, Russell D. Coronary artery bypass grafting (CABG) and cognitive decline: a review. J Neurol Sci. 2005;229-230:65-67.
21. Newman MF, Kirchner JL, Phillips-Bute B, et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med. 2001;344:395-402.
22. Stolz E, Gerriets T, Kluge A, et al. Diffusion-weighted magnetic resonance imaging and neurobiochemical markers after aortic valve replacement: implications for future neuroprotective trials? Stroke. 2004;35:888-892.
23. Aldea GS, Soltow LO, Chandler WL, et al. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiovasc Surg. 2002;123:742-755.
24. Ben-Abraham R, Weinbroum AA, Dekel B, et al. Chemokines and the inflammatory response following cardiopulmonary bypass: a new target for therapeutic intervention? A review. Paediatr Anaesth. 2003;13:655-661.
25. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1993;55:552-559.
26. Chew ST, Newman MF, White WD, et al. Preliminary report on the association of apolipoprotein E polymorphisms, with postoperative peak serum creatinine concentrations in cardiac surgical patients. Anesthesiology. 2000;93:325-331.
27. Clermont G, Vergely C, Jazayeri S, et al. Systemic free radical activation is a major event involved in myocardial oxidative stress related to cardiopulmonary bypass. Anesthesiology. 2002;96:80-87.
28. Holmes JH, Connolly NC, Paull DL, et al. Magnitude of the inflammatory response to cardiopulmonary bypass and its relation to adverse clinical outcomes. Inflamm Res. 2002;51:579-586.
29. Miller BE, Levy JH. The inflammatory response to cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1997;11:355-366.
30. Wilson CJ, Finch CE, Cohen HJ. Cytokines and cognition: the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc. 2002;50:2041-2056.
31. Ingebrigtsen T, Romner B. Serial S-100 protein serum measurements related to early magnetic resonance imaging after minor head injury: case report. J Neurosurg. 1996;85:945-948.
32. Bakay RA, Ward AA Jr. Enzymatic changes in serum and cerebrospinal fluid in neurological injury. J Neurosurg. 1983;58:27-37.
33. van Engelen BG, Lamers KJ, Gabreels FJ, et al. Age-related changes of neuron-specific enolase, S-100 protein, and myelin basic protein concentrations in cerebrospinal fluid. Clin Chem. 1992;38:813-816.
34. Herrmann M, Curio N, Jost S, et al. Protein S-100B and neuron specific enolase as early neurobiochemical markers of the severity of traumatic brain injury. Restor Neurol Neurosci. 1999;14:109-114.
35. Johnsson P, Blomquist S, Luhrs C, et al. Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation. Ann Thorac Surg. 2000;69:750-754.
36. Teunissen CE, Dijkstra C, Polman C. Biological markers in CSF and blood for axonal degeneration in multiple sclerosis. Lancet Neurol. 2005;4:32-41.
37. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med. 2006;354:353-365.
38. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg. 2002;21:232-244.
39. Luyten CR, van Overveld FJ, De Backer LA, et al. Antioxidant defence during cardiopulmonary bypass surgery. Eur J Cardiothorac Surg. 2005;27:611-616.
40. Ohata T, Sawa Y, Kadoba K, et al. Normothermia has beneficial effects in cardiopulmonary bypass attenuating inflammatory reactions. ASAIO J. 1995;41:M288-M291.
41. Baufreton C, Allain P, Chevailler A, et al. Brain injury and neuropsychological outcome after coronary artery surgery are affected by complement activation. Ann Thorac Surg. 2005;79:1597-1605.